BioCryst Pharmaceuticals
BCRX
#4882
Rank
C$2.78 B
Marketcap
C$10.83
Share price
0.79%
Change (1 day)
7.18%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): C-$1.68

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$2.03. In 2022 the company made an earnings per share (EPS) of C-$1.87 a decrease over its 2021 EPS that were of C-$1.45.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$1.68-10.19%
2022C-$1.8729.13%
2021C-$1.45-4.63%
2020C-$1.5210.2%
2019C-$1.380%
2018C-$1.3825.64%
2017C-$1.104%
2016C-$1.0627.12%
2015C-$0.83-13.24%
2014C-$0.9623.64%
2013C-$0.77-30.38%
2012C-$1.11-37.3%
2011C-$1.7765.79%
2010C-$1.07117.14%
2009C-$0.49-46.15%
2008C-$0.92-26.97%
2007C-$1.25-40.67%
2006C-$2.1148.51%
2005C-$1.421%
2004C-$1.4138.89%
2003C-$1.01-25%
2002C-$1.35231.03%
2001C-$0.41-56.72%
2000C-$0.9491.43%
1999C-$0.492.94%
1998C-$0.48-55.84%
1997C-$1.0811.59%
1996C-$0.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
C-$4.37 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.05-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C-$3.70 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C-$0.28-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C-$2.14 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.13 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C-$0.62-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$4.48 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$4.84 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA